Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
222.8 CHF | -2.19% | +0.68% | -8.88% |
10:45am | Wegovy weight loss sustained for four years in trial, Novo Nordisk says | RE |
07:27am | Lonza Affirms FY24 Sales Outlook, Raises Mid-term Growth Guidance | MT |
Sales 2024 * | 60B 66.07B | Sales 2025 * | 63.79B 70.25B | Capitalization | 184B 203B |
---|---|---|---|---|---|
Net income 2024 * | 13.46B 14.82B | Net income 2025 * | 14.87B 16.37B | EV / Sales 2024 * | 3.3 x |
Net Debt 2024 * | 14.25B 15.69B | Net Debt 2025 * | 8.18B 9.01B | EV / Sales 2025 * | 3.01 x |
P/E ratio 2024 * |
13.3
x | P/E ratio 2025 * |
12.1
x | Employees | 103,605 |
Yield 2024 * |
4.27% | Yield 2025 * |
4.41% | Free-Float | 88.91% |
Latest transcript on Roche Holding AG
1 day | -2.46% | ||
1 week | +0.86% | ||
Current month | +1.18% | ||
1 month | -0.84% | ||
3 months | -1.76% | ||
6 months | -6.84% | ||
Current year | -8.71% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 02-12-31 | |
Severin Schwan
CHM | Chairman | 57 | 07-12-31 |
Alan Hippe
DFI | Director of Finance/CFO | 57 | 11-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bernard Poussot
BRD | Director/Board Member | 72 | 15-03-02 |
Director/Board Member | 59 | - | |
Director/Board Member | 66 | 95-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
9.03% | 121 M€ | -.--% | - | |
8.46% | 17 M€ | +6.46% | - | |
4.67% | 2 M€ | -.--% | ||
2.85% | 6 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 222.5 | -2.33% | 434 468 |
24-05-13 | 227.8 | +1.20% | 1,268,808 |
24-05-10 | 225.1 | +1.26% | 1,320,691 |
24-05-08 | 222.3 | +0.45% | 1,238,923 |
24-05-07 | 221.3 | +1.28% | 1,167,856 |
Delayed Quote Swiss Exchange, May 14, 2024 at 04:43 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.71% | 203B | |
+29.98% | 682B | |
+31.99% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.32% | 240B | |
+9.58% | 209B | |
+7.09% | 165B | |
-1.22% | 161B |
- Stock Market
- Equities
- ROG Stock